Global Medtech Contract Development and Manufacturing Market

Deal activity in the medtech contract development and manufacturing organization (CDMO) sector declined in the first half of 2025 due to economic uncertainty. Targeted capabilities continued to diversify, and financial sponsors continued to outpace corporate buyers. More than half of transactions targeted US companies and vertical integration remained the key driver of inorganic growth.

Access current medtech CDMO M&A market insights, including H1 2025 data on:

• Recent M&A activity
• M&A geography
• Target manufacturing capabilities
• Target end markets